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Abstract We present the case of an elderly woman which
demonstrates how AF therapy in aged individuals is par-
ticularly challenging for the presence of complex condi-
tions. The rhythm- or the rate control strategy must be
carefully chosen based on individual risk profile. Oral
anticoagulant therapy must be wisely managed to maxi-
mize benefits—in terms of stroke and dementia control—
and to reduce complications.
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Introduction
Atrial fibrillation (AF) is the most frequent sustained
arrhythmia observed in elderly people [1]. Moreover,
mortality and some clinically relevant complications of
AF, such as stroke, heart failure and dementia, are partic-
ularly common among aged individuals [1]. The clinical
picture of elderly arrhythmic patients is often worsened by
comorbidities and by a response to drug therapy which
could be different from that observed at younger ages.
Case report
We present the case of an 83-year-old woman. She was
completely independent in basic and instrumental activities
of daily living (IADL) and her mini mental state exami-
nation (MMSE) was quite normal. She was unmarried and
lived alone. Before retirement, she worked as an herbalist
and from this activity derived great skepticism in doctors
and drug therapy. She does not drink coffee or alcoholic
beverages and stopped smoking about 40 years ago. Only
arterial hypertension was referred among cardiovascular
risk factors. Clinical history resulted positive also for lung
tuberculosis at young age, presence of uterine fibroids,
which brought to radical hysterectomy at 35 years, chole-
cystectomy for gallbladder stones at 61 years, inguinal and
crural hernias which were surgically repaired, bilateral
cataract surgery and diagnosis of Sjogren syndrome. Her
first episode of AF had been diagnosed 15 years before. All
events, with a mean heart rate of about 140 bpm, were
characterized by palpitations, had a variable length and
were often triggered by meals. The echocardiogram was
normal. ECG Holter had previously revealed an intermit-
tent, heart-rate dependent, left bundle branch block and a
CT coronary angiography showed a low probability of
disease.
Despite a high-risk CHA2DS2-VASc score, which was
equal to 4 (arterial hypertension, age C75 years, female
gender), she had always refused, for personal reasons, to
start continuous therapy with oral anticoagulants and anti-
arrhythmic agents. Regardless the frequent advice of her
doctor, she had decided to control AF episodes with a ‘‘pill-
in-the-pocket’’ strategy (propafenone, 300 mg p.o.) [2]. In
only one occasion, 4 years before, the patient was treated
with external cardioversion. In the last 12 months,
arrhythmic episodes became more frequent, with a cadence
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of about once a week. The old lady arrived in the emer-
gency department at 2.00 PM on September 10th, 2014.
She had contacted the Emergency Medical Service because
of marked fatigue. Immediately after the arrival of the
ambulance, she developed mental confusion, arterial
hypotension and bradycardia. At the admission, cold
diaphoresis, nausea and vomiting appeared. Repeated ECG
demonstrated sinus bradycardia followed by sinus rhythm,
with important electrical alterations characterized by 1st
degree AV conduction block (PR length: 250 ms) and
persistent QRS enlargement (QRS length: 240 ms with
marked disturbance of left bundle branch conduction)
(Fig. 1a). Once the patient was able to collaborate, it
appeared that after having felt palpitations, she erroneously
took an overdose of propafenone (600 mg—two tablets,
and not the usual dose of 300 mg—one tablet) because of
the excitement for the arrival of her family. The old lady
was then transferred to a monitored bed, where symptoms
and ECG alterations disappeared. After 12 h from her
arrival in hospital, arterial pressure was 165/75 mmHg and
HR 73 bpm. Body weight was 60 kg, height 162 cm (BMI:
22.9 kg/m2). Blood tests revealed mild anemia (Hb: 11.4 g/
dL, mean corpuscular volume: 82.6 fL), normal blood urea
nitrogen and creatinine concentrations (0.33 g/L and
0.89 mg/dL, respectively), transaminases and TSH values
in the normal range. Troponin I did not show any change of
clinical significance during the hospitalization. Interest-
ingly, pro-BNP values decreased from 1033 pg/mL, at
baseline, to 288 pg/mL, at 72 h. Our patient remained in
hospital 4 days. During her stay, she experienced two
further episodes of AF, which required administration of
i.v. amiodarone. No persistent alterations of conduction
Fig. 1 ECGs of the patient.
Panel a after her arrival at the
Emergency Department. It is
possible to see the P waves (red
circles) and the deep alterations
of AV (PR length: 250 ms) and
intraventricular (QRS length:
240 ms; blue circles)
conduction. Panel b Atrial
fibrillation relapse recorded
while the patient was in
hospital; the intraventricular
conduction is normal after
propafenone washout (blue
circles)
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were observed at ECG (Fig. 1b). The drug effectively
stopped the arrhythmia and the old lady was discharged
with amiodarone and warfarin on September 14th. Because
of a misinterpretation of hospital prescription, warfarin was
maintained at a daily dose of 3.75 mg for 4 days. This
determined a marked increase of INR values, which forced
to the administration of Vitamin K (2 mg p.o.) (Fig. 2).
INR dropped immediately in the normal therapeutic range.
However, in the following days, despite a relevant reduc-
tion of warfarin daily dose (between 0 and 1.25 mg), it was
possible to observe a marked instability of INR values,
which ranged from 1.6 to 4.5 (Fig. 2). HAS-BLED score
was 4 (arterial hypertension, INR instability, age[65 -
years, use of non-steroidal anti-inflammatory agents). On
this basis, we started treatment with a new oral anticoag-
ulant. Since then, in the subsequent 9 months, our old
patient maintained a stable clinical condition. No AF
relapses were recorded; no adverse effects related to oral
anticoagulation were experienced. The patient is in touch
with our center to which she constantly sends clinical
information. She is still independent, living a socially
active life and fostering her interests. At this regard, she
has recently sent us an e-mail about the need to save Ice-
landic whales.
Discussion
This case clearly shows the multiple problems correlated to
AF management in elderly individuals. Moreover, the
selection of the most appropriate plan is sometimes made
difficult for the existence of conflicting evidence in liter-
ature. A rhythm control strategy is more rarely chosen in
aged patients and, indeed, the AFFIRM Study showed an
increased mortality with this approach in subjects older or
equal to 70 years [3]. Furthermore, the ‘‘pill-in-the-pocket’’
therapy should not be employed over 75 years of age [2]
and strong evidence proves the high adverse event rate
associated with all anti-arrhythmic agents [1]. However,
the same AFFIRM Study demonstrated that, independently
of the adopted therapeutic strategy, the presence of sinus
rhythm was significantly associated with a reduced mor-
tality during the follow-up [4]. Specifically regarding
elderly people, AF development independently accelerated
the decline of cognitive performance [5]. An item of the
IADL, explicitly explores the possibility of an elderly
patient to take a medication in a correct dosage at a correct
time. Our patient, completely independent in her usual
tasks, failed to assume the right dose of propafenone
because of an emotional stress (i.e., the visit of her rela-
tives). It is reported that anxiety symptoms can signifi-
cantly decrease memory performance and negatively
influence executive functioning capabilities of older adults
[6]. Thus, even temporary mood disturbances can exert
important effects on the possibility to properly follow a
therapeutic scheme in elderly individuals.
Concerning oral anticoagulation, undertreatment of aged
subjects currently represents an important issue [7]. In our
old lady, we observed an initial marked increase of INR
values determined by a misinterpretation of warfarin pre-
scription. At this regard, to limit the hemorrhagic compli-
cations of an oral anticoagulant regimen in the elderly, it
has been shown that it is necessary to have a careful
management plan conducted by experienced centers [8]. In
our patient, we observed an important instability of INR
and a related low time in therapeutic range (TTR), even
after having begun a more solicitous monitoring protocol.
Advanced age, female gender and the use of amiodarone
itself could be at least in part responsible of this unsatis-
factory result [9]. Importantly, it has been recently
demonstrated the complex relation between anticoagula-
tion and dementia in older AF patients. In fact, the lower
the MMSE, the lower is the TTR [10]; furthermore, in
elderly subjects without dementia or cerebrovascular dis-
eases at baseline, evidence shows that lower TTR is asso-
ciated with a higher long-term risk of dementia [11]. The
choice of a new oral anticoagulant with a specific action on
the coagulation cascade, a more defined pharmacologic
profile, a lower interaction with drugs or meals, fewer
monitoring requirements and a significantly reduced risk of
intracranial hemorrhage, revealed to be the most
appropriate.
In conclusion, AF therapy in elderly individuals is par-
ticularly challenging for the presence of complex condi-
tions. The rhythm- or the rate control strategy must be
carefully chosen based on individual risk profile. Oral
anticoagulant therapy must be wisely managed in order to
maximize benefits—in terms of stroke and dementia con-
trol—and to reduce complications.
Fig. 2 Daily trends of INR values (blue solid line) and of warfarin
dose (red solid line). The blue dotted lines represent the INR range for
patients with non valvular atrial fibrillation; the red dotted line
identifies the INR value from which the hemorrhagic risk increases.
The arrow is in correspondence of vitamin K administration
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